Oncology Ventures

www.oncology.ventures

VCMatch tracks Oncology Ventures as an investor focused on Digital Health, Healthtech, and AI/ML companies, Seed and Series A rounds, and United States and Latin America markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Seed, Series A

Focus Areas

Digital Health, Healthtech, AI/ML

Geography

United States and Latin America

Investment Thesis

Oncology Ventures is a mission-driven VC that targets the large, underfunded opportunity in cancer care by backing data-driven and digital technologies that close evidence and access gaps across the entire cancer care continuum. The firm explicitly focuses on funding solutions “from early detection to patient navigation to data access and AI-powered treatment optimization,” emphasizing non-drug infrastructure and real-world data platforms that turn existing knowledge into lives saved.

Is Oncology Ventures right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Oncology Ventures is most relevant for founders raising Seed and Series A rounds in Digital Health, Healthtech, AI/ML, and Enterprise SaaS, especially across United States and Latin America.

Focus statement

"We invest in healthcare data companies tackling the biggest problems in cancer care" — specifically early detection, precision diagnostics, care navigation, survivorship, clinical trial enablement and AI/digital infrastructure that improves outcomes and reduces cost.

Value Add

Founder-driven perspective: firm was founded by cancer survivor Ben Freeberg who brings a patient perspective and operator experience (investor, Optum Ventures; operator at Thyme Care).
Cancer-specific, end-to-end focus: explicit emphasis on the full oncology care continuum (early detection → treatment optimization → survivorship) and "non-drug infrastructure".
Data + AI orientation: prioritizes healthcare data companies, real-world evidence platforms, AI-powered treatment and workflow optimization, and clinical-trial/digital infrastructure.
Deep industry network and clinical credibility: advisory roster includes leaders from Flatiron, UnitedHealth, City of Hope and oncology practice networks, enabling strategic buyer and partner introductions.
Active, operational support beyond capital: founder and team position themselves as responsive, operationally helpful partners (testimonials highlight being "first to respond," connecting to strategic partners, and mobilizing resources).